Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 93% confidence The document is titled “분기보고서 6.5 (주)알파에이아이” covering the period from 2026-01-01 to 2026-03-31. It contains detailed interim financial disclosures: corporate overview, subsidiaries, capital changes, share capital tables, management changes, and statutory information. This is the full quarterly report itself (not merely an announcement or summary), thus fitting the definition of an Interim / Quarterly Report. Q1 2026
2026-05-15 Korean
주주총회소집결의 (임시주주총회)
Regulatory Filings Classification · 63% confidence The document is a resolution to convene an extraordinary shareholders’ meeting (임시주주총회 소집결의) – it provides date, time, place, record date, and board resolution details. It is a general regulatory announcement of an upcoming shareholders’ meeting rather than the meeting materials themselves or the results. It does not contain financial statements or proxy solicitation details beyond the notice. This best fits into the catch-all Regulatory Filings category (RNS).
2026-05-13 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 85% confidence The document is a short regulatory announcement setting the record date (book closure period) for determining shareholders’ rights for an upcoming meeting. It does not contain substantive financial statements or an actual report, nor is it a dividend notice, share issuance, or voting results. It is a general regulatory disclosure (표준 공시) about record date setting, which falls under Regulatory Filings (RNS).
2026-05-13 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 87% confidence The document is a Korean Major Event Report (주요사항보고서) announcing and then correcting detailed terms for the issuance of a 3.5 billion KRW private convertible bond, including maturity, interest, conversion mechanics, put options, and related share quantities. This is clearly a financing disclosure about a bond issuance (capital-raising activity) rather than a full financial statement, dividend notice, or governance filing. Under the filing categories, it best fits “Capital/Financing Update (CAP).”
2026-04-28 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 95% confidence The document is a detailed Material Information Report (“주요사항보고서”) filed with the Korean Financial Services Commission and Korea Exchange, outlining the decision to issue convertible bonds (terms, interest, maturity, conversion details, put option, etc.) and a correction to a prior filing. This is not an annual or interim report, nor a simple publication announcement, but a substantive financing activity disclosure. Therefore it fits the Capital/Financing Update category (CAP).
2026-04-28 Korean
[기재정정]타법인주식및출자증권취득결정
Regulatory Filings Classification · 42% confidence The document is a Korean regulatory disclosure titled “타법인주식및출자증권취득결정” (decision to acquire shares and equity securities of another company), complete with target details, acquisition amount, and corrigendum. It is not an earnings release, no AGM materials, no dividend notice, not a board change, not financial statements, and there is no specific category for an external equity investment decision. Therefore it falls under general Regulatory Filings (fallback category RNS).
2026-04-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.